ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Mayo Clinic
Rochester, Estados UnidosPublicaciones en colaboración con investigadores/as de Mayo Clinic (7)
2022
2021
-
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
European Journal of Cancer, Vol. 154, pp. 246-252
2019
-
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study
Annals of Oncology, Vol. 30, Núm. 1, pp. 124-131
-
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study
Oncologist, Vol. 24, Núm. 2, pp. 185-192
2018
2015
-
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): A randomised, double-blind, multicentre, phase 3 study
The Lancet Oncology, Vol. 16, Núm. 5, pp. 499-508
2011
-
Therapy innovations: Tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors
Cancer and Metastasis Reviews, Vol. 30, Núm. SUPPL. 1